Healthcare information technology (HIT) services provider Calyx announced it will merge with Invicro and acquire 100% of the company from Realm IDx.
The two firms will integrate to "span the complete R&D lifecycle from discovery through research and development to post-marketing, across a number of areas including imaging biomarkers, core lab services, analytics, and software,” Calyx CEO David Herron stated in an announcement. The companies also noted that their work will focus on radioligand therapies.
In 2021, Calyx branded out of a split of Parexel Informatics. Calyx's Invicro transaction is expected to be completed in the second quarter of 2024.
